Incentives And Less Fear Of Failure: How GSK Is Driving Early-Stage Research In Its DPUs

Most of GlaxoSmithKline's early-stage research organizations, discovery performance units, survive a three-year review cycle, with co-localization, monetary incentives and career support leading a change of culture.